PHARMA C KEYSERS
0567.566.004 · rovalta.com · 25/09/2026
PHARMA C KEYSERS
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOPHARMA C KEYSERS is a Private limited company incorporated in 2014. Its main activity is: Management consultancy activities. Its registered office is in Tielt-Winge.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0567.566.004
- Incorporation
- 13/10/2014
- Legal form
- Private limited company
- Registered office
- Wersbeekstraat 12
3391 Tielt-Winge · FlandreSee on map - Contributed capital
- 1 708 000,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -15,6 k € | -0.1% | -15,6 k € | -200% | 15,6 k € | +274% | -9 k € | -186% | -3,1 k € |
| EBITDA | -16,8 k € | -0.1% | -16,8 k € | -217% | 14,4 k € | +247% | -9,8 k € | -134% | -4,2 k € |
| Operating result | -16,8 k € | -0.1% | -16,8 k € | -217% | 14,4 k € | +247% | -9,8 k € | -134% | -4,2 k € |
| Net result | -17,2 k € | +0.2% | -17,2 k € | -222% | 14,1 k € | +238% | -10,2 k € | -117% | -4,7 k € |
| Balance sheet | |||||||||
| Equity | 1,7 M € | -1.0% | 1,7 M € | -1.0% | 1,7 M € | +0.8% | 1,7 M € | -0.6% | 1,7 M € |
| Total assets | 1,7 M € | -0.2% | 1,7 M € | -0.3% | 1,7 M € | +0.3% | 1,7 M € | -0.2% | 1,7 M € |
| Cash | 3 k € | -22.3% | 3,9 k € | -53.4% | 8,4 k € | +24.0% | 6,7 k € | -7.5% | 7,3 k € |
| Debts | 66,7 k € | +28.8% | 51,8 k € | +30.5% | 39,7 k € | -19.6% | 49,4 k € | +13.1% | 43,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Wersbeekstraat 12 3391 Tielt-Winge| Company | CBE no. |
|---|---|
APOTHEEK GREET KEYSERS● Active | 0478.620.071 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/03/2026 | 08/05/2025 | 21/03/2024 | 30/03/2023 | 25/03/2022 | 30/03/2021 |
| General meeting | 27/02/2026 | 28/02/2025 | 23/02/2024 | 24/02/2023 | 25/02/2022 | 26/02/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 27/02/2026 | 08/03/2026 | Dutch | |
| Abridged model | 30/09/2024 | 28/02/2025 | 08/05/2025 | Dutch | |
| Abridged model | 30/09/2023 | 23/02/2024 | 21/03/2024 | Dutch | |
| Abridged model | 30/09/2022 | 24/02/2023 | 30/03/2023 | Dutch | |
| Abridged model | 30/09/2021 | 25/02/2022 | 25/03/2022 | Dutch | |
| Abridged model | 30/09/2020 | 26/02/2021 | 30/03/2021 | Dutch | |
| Abridged model | 30/09/2019 | 28/02/2020 | 05/03/2020 | Dutch | |
| Abridged model | 30/09/2018 | 22/02/2019 | 12/03/2019 | Dutch | |
| Abridged model | 30/09/2017 | 23/02/2018 | 13/03/2018 | Dutch | |
| Abridged model | 30/09/2016 | 24/02/2017 | 27/02/2017 | Dutch | |
| Abridged model | 30/09/2015 | 26/02/2016 | 01/03/2016 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-17,2 k €↑
- 2024Annual accounts 2024-17,2 k €↓
- 2023Annual accounts 202314,1 k €↑
- 2022Annual accounts 2022-10,2 k €↓
- 2021Annual accounts 2021-4,7 k €↑
- 2020Annual accounts 2020-6,1 k €↓
- 2019Annual accounts 2019-3,9 k €↑
- 2018Annual accounts 2018-11,5 k €↓
- 2017Annual accounts 201716,8 k €↑
- 2016Annual accounts 2016-13,2 k €↓
- 2015Annual accounts 2015-538,6 €
- 13/10/2014IncorporationPrivate limited company